Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Interpace Diagnostics Group Inc (NASDAQ:IDXG)

1.48
Delayed Data
As of 3:59pm ET
 0.00 / 0.00%
Today’s Change
0.70
Today|||52-Week Range
19.80
-66.36%
Year-to-Date
No recent news for Interpace Diagnostics Group Inc.

Today’s Trading

Previous close1.48
Today’s open1.50
Day’s range1.44 - 1.53
Volume1,155,536
Average volume (3 months)2,949,662
Market cap$32.8M
Dividend yield--
Data as of 3:59pm ET, 10/16/2017

Growth & Valuation

Earnings growth (last year)+75.05%
Earnings growth (this year)+13.61%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+38.73%
P/E ratioNM
Price/Sales0.61
Price/Book0.49

Competitors

 Today’s
change
Today’s
% change
BMRABiomerica Inc0.000.00%
TRILTrillium Therapeutic...-0.05-0.83%
APHBAmpliPhi Biosciences...+0.04+3.45%
GALTGalectin Therapeutic...-0.26-10.12%
Data as of 4:09pm ET, 10/16/2017

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$13.1M
Annual profit (last year)-$9.7M
Net profit margin-64.27%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
Jack E. Stover
Senior Vice President-
Operations
Glenn Gershon
Corporate headquarters
Parsippany, New Jersey

Forecasts